Manilith 400 SR Tablet
Product Info
Prescription required | Yes |
Marketer | Psychocare Health Pvt Ltd |
Active Ingredient | Lithium carbonate (400mg) |
Storage | Store below 30°C |
Chemical Class | Organic Carbonic Acids |
Habit Forming | No |
Therapeutic Class | NEURO CNS |
Action Class | Mood stabilizers |
User Rating | 4.2 |
User Reviews | 564 |
FAQ
Manilith 400 SR Tablet Reviews
Manilith 400 SR should be taken with food. However, it is advised to take it at the same time each day as this helps to maintain a consistent level of medicine in the body. Do not skip any doses and finish the full course of treatment even if you feel better. If you have missed a dose, take it as soon as you remember it. You should continue to take this medicine for as long as the doctor advises and do not stop taking it suddenly as it may result in harmful effects.
Side effects associated with the use of this medicine include tremors, slurred speech, uncoordinated body movements, nausea, Vomiting, acne, increased white blood cell count, and memory impairment. It may also cause hair loss, enlarged thyroid gland, skin rash, and increased thirst. This medicine may also cause weight gain and to control it, you should have a balanced diet and exercise regularly. If you have been taking this medicine for a long time then regular monitoring of thyroid and kidney function may be required.
How Manilith 400 SR Tablet Works
How to Use Manilith 400 SR Tablet
Benefits of Manilith 400 SR Tablet
- In Mania: Mania means extremely excited or elevated mood. Manilith 400 SR helps calm the mood and relax the nerves. This stabilises the mood and prevents the symptoms of mania from recurring again. Taking Manilith 400 SR will ensure that you have a better social life and are able to do daily activities more comfortably.
- In Bipolar disorder: Manilith 400 SR works to restore the normal balance of nerve activity in your brain. It can help prevent extreme changes in mood and help you feel less agitated. You may experience fewer episodes of low mood. It can take several weeks for this medicine to work and you may still feel low during this time. It is likely that you will take this medicine for at least six months but possibly much longer. It needs to be taken regularly to work effectively. Do not stop taking it unless your doctor advises you to. You should continue to eat well and keep fit to reduce symptoms of bipolar disorder.
Uses of Manilith 400 SR Tablet
- Bipolar disorder
- Mania
Manilith 400 SR Tablet Side Effects
Safety Tips
Quick Tips
- Do not drive or do anything that requires mental focus until you know how it affects you.
- Inform your doctor if you have persistent stomach upset, problems with your speech, or extreme drowsiness. Your dose may need to be adjusted.
- Your lithium blood levels, thyroid function, and kidney function may be monitored as long as you take this medicine.
- Do not stop taking the medication suddenly without talking to your doctor.
- It may also be used for the treatment of mania.
- Do not take Manilith 400 SR if you are pregnant or breastfeeding.
- Manilith 400 SR is one of the most effective long-term treatment for bipolar disorder.
- Monitor your weight during treatment as Manilith 400 SR can cause weight gain.
- It may cause diarrhea and dehydration. Drink plenty of water and and use normal amounts of salt. Inform your doctor if you start or stop a low-salt diet.
References
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Lithium. [Updated 2020 Jan 20].
- Central Drugs Standard Control Organisation (CDSCO).
- Meltzer H. Antipsychotic Agents & Lithium. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 502-504.
- Lithium Carbonate [Patient Information Leaflet]. Ahmedabad, Gujarat: Torrent Pharmaceuticals :Ltd.; 2022.
- Stahl SM, editor. Lithium. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 349-54.